Patient Data Reporting Applications & Studies

81. Large NCI-Designated Hospital System Trains 400 End Users, Resulting In Increased Levels Of Efficiency And Consistency 6/28/2022

    Learn how an eLearning solution was used to help overburdened trainers from a large National Cancer Institute (NCI)-designated hospital system.

82. Vanderbilt's Advice For Sponsors: How To Make Working With Your EDC Easier For Sites 5/24/2022

    Learn how research sites like Vanderbilt University Medical Center speed study timelines and drive higher quality data entry with a modern EDC.

83. Top 10 Biopharma Achieves Significant Regulatory Efficiency 5/23/2022

    Discover how a top 10 biopharmaceutical company expanded its regulatory efficiency and automated key workflows between their IRB Platform and their electronic master file (eTMF).

84. A Leading Academic Medical Center Monitors Newly Diagnosed Myeloma Patients 5/20/2022

    Learn how eCOA helped to motivate patients and increased engagement around experiences outside of the clinical setting, which otherwise may have gone unmentioned.

85. Implantable Medical Device 11/29/2021

    A leading global medical device company received a warning letter from the United States Food and Drug Administration (FDA), citing a failure to comply with post-approval ePRO (electronic patient-reported outcome assessments) requirements related to a cleared implantable medical device. Find out what happens in the available case study.

86. The Impact Of Mobile App Technology On eCOA 10/27/2021

    Patients are vital to the success of any clinical trial. Yet many trials struggle to keep patients engaged for the duration of the study.

87. Achieving 97% Patient Compliance, Increased Patient Engagement 9/23/2021

    In a proof-of-concept for a decentralized hybrid study, explore how Electronic Patient-Reported Outcomes (ePRO) technology was used to assess the results of varying digital therapies and the feasibility of conducting a largely virtual clinical study in a fibromyalgia population.

88. Accelerating Database Lock: Adaptive Design & Remote Monitoring 8/17/2021

    Reach database lock in less than one month instead of a year. That’s what one large pharmaceutical company achieved by providing real-time remote access to validated clinical data.

89. Using De-Identified Linked Real-World Data To Create An External Control Arm 7/13/2021

    A pharmaceutical company designed its Phase II study of a novel agent to treat metastatic non-small cell lung cancer driven by a rare subtype of EGFR genetic mutation. They needed to construct a control arm that had cohort of patients with the specific subtype of metastatic EGFR non-small cell lung cancer whose disease progressed despite taking platinum-based chemotherapy. By utilizing a platform that allowed them to collect data across three vendors that represented unique patients proved successful and enabled the company to move forwards with the Phase II pivotal trial.

90. Virtual Study Yields High Compliance & Retention Rates 6/21/2021

    Clinical research studies involving repeated patient reported outcome measures (PROs) face several challenges. Patients may fail to complete individual PROs, whether at all or within a specified time (i.e., reduced compliance). Patients may cease participating in a study altogether, dropping out before all study procedures are completed (i.e., reduced retention). Read how an app was used in a study that enrolled 124 patients resulted in the majority of participants in the study being 100% compliant and retained through study end.